☆ 4.6 Article Proceedings Paper

New antiplatelet drugs and new oral anticoagulants

BRITISH JOURNAL OF ANAESTHESIA (2016)

Journal

BRITISH JOURNAL OF ANAESTHESIA

Volume 117, Issue -, Pages 74-84

Publisher

ELSEVIER SCI LTD

DOI: 10.1093/bja/aew214

Keywords

antiplatelet agents; anticoagulants and haemorrhage; blood coagulation tests

Categories

Anesthesiology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Abstract

In our daily anaesthetic practice, we are confronted with an increasing number of patients treated with either antiplatelet or anticoagulant agents. During the last decade, changes have occurred that make the handling of antithrombotic medication a challenging part of anaesthetic perioperative management. In this review, the authors discuss the most important antiplatelet and anticoagulant drugs, the perioperative management, the handling of bleeding complications, and the interpretation of some laboratory analyses related to these agents.

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

Management of bone marrow biopsy related bleeding risks: a retrospective observational study

Lucile Grange, Martin Killian, Emmanuelle Tavernier, Ludovic Fouillet, Denis Guyotat, Emilie Chalayer

Summary: Bone marrow biopsies are commonly used for diagnosing and predicting hematological diseases. This study aimed to analyze the management of patients at high hemorrhagic risk, particularly thrombocytopenic patients, and those on antithrombotic drugs. Results showed that thrombocytopenic patients have a significant bleeding risk, and temporary cessation of anticoagulant treatment before biopsy does not increase the risk of thrombotic complications.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Platelets and Their Role in Hemostasis and Thrombosis-From Physiology to Pathophysiology and Therapeutic Implications

Alina Scridon

Summary: This article comprehensively explores the complex role of platelets in hemostasis and thrombosis, discussing their importance in clinical medicine, and studying hemostatic platelet-related disorders and antithrombotic therapies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Pharmacology & Pharmacy

SHR2285, the first selectively oral FXIa inhibitor in China: Safety, tolerability, pharmacokinetics and pharmacodynamics combined with aspirin, clopidogrel or ticagrelor

Tingting Ma, Yanli Dong, Lei Huang, Yuanxun Yang, Yan Geng, Fei Fei, Pinhao Xie, Yu Zhao, Hui Lin, Zeyu Yang, Yun Jin, Xitong Ju, Runbin Sun, Juan Li

Summary: This study evaluated the safety and pharmacodynamics of SHR2285, the first oral coagulation factor XIa (FXIa) inhibitor developed in China, in combination with aspirin, clopidogrel or ticagrelor in healthy subjects. Results showed that SHR2285 was well tolerated, with no increased risk of bleeding, and effectively inhibited FXI activity and prolonged APTT when combined with these antiplatelet agents.

FRONTIERS IN PHARMACOLOGY (2022)

Add to Collection

Article Surgery

Antithrombotic Agent Use in Elderly Patients Sustaining Low-Level Falls

Michael J. Meade, Abhinay Tumati, Chanak Chantachote, Emily C. Huang, Daniel N. Rutigliano, Jerry A. Rubano, James A. Vosswinkel, Randeep S. Jawa

Summary: This study reviewed elderly patients admitted for low-level falls aged 65 and older, finding that the use of antithrombotic agents was common and associated with an increased rate of intracranial hemorrhage (ICH); anticoagulants were also associated with higher mortality rates.

JOURNAL OF SURGICAL RESEARCH (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Pharmacology and Clinical Development of Factor XI Inhibitors

Antonio Greco, Claudio Laudani, Marco Spagnolo, Federica Agnello, Denise Cristiana Faro, Simone Finocchiaro, Marco Legnazzi, Maria Sara Mauro, Placido Maria Mazzone, Giovanni Occhipinti, Carla Rochira, Lorenzo Scalia, Davide Capodanno

Summary: Therapeutic anticoagulation is used to prevent or treat blood clots, but it can increase the risk of bleeding. Inhibitors of Factor XI (FXI) show promise in reducing the adverse events of anticoagulation. Large-scale phase 3 clinical trials are needed to confirm the role of FXI inhibitors and determine their clinical indications.

CIRCULATION (2023)

Add to Collection

Review Surgery

Impact of antiplatelet agents and anticoagulants on the performance of fecal immunochemical tests: a systematic review and meta-analysis

Yoon Suk Jung, Eui Im, Chan Hyuk Park

Summary: The use of antithrombotic agents significantly lowered the PPV of FIT for detecting advanced colorectal neoplasia, potentially increasing false positives.

SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2022)

Add to Collection

Article Critical Care Medicine

Coagulations Studies Do Not Correlate With Each Other or With Hematologic Complications During Pediatric Extracorporeal Membrane Oxygenation*

Shyam J. Deshpande, Sally Vitali, Ravi Thiagarajan, Steven Brediger, Michael McManus, Alon Geva

Summary: In children supported with extracorporeal membrane oxygenation, there is poor correlation between heparin dose and common laboratory measures of anticoagulation, and laboratory measures also correlate poorly with each other. Neither heparin dose nor laboratory measures are significantly associated with hemorrhage or thrombosis. Further research is needed to identify more effective measures of anticoagulation to reduce morbidity and mortality in patients on extracorporeal membrane oxygenation.

PEDIATRIC CRITICAL CARE MEDICINE (2021)

Add to Collection

Review Medicine, Research & Experimental

Mechanisms and interactions in concomitant use of herbs and warfarin therapy: An updated review

Paula Mendonca Leite, Maria Auxiliadora Parreiras Martins, Maria das Gracas Carvalho, Rachel Oliveira Castilho

Summary: Warfarin is a complex drug with high potential for interactions with drugs, foods, and herbal medicines, especially with herbal medicines. Despite the lack of research on herb-warfarin interactions, clinical management of these interactions is known to be effective. Caution should be exercised when using these herbal medicines to manage potential risks.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Add to Collection

Article Medicine, General & Internal

Preventing Thrombohemorrhagic Complications of Heparinized COVID-19 Patients Using Adjunctive Thromboelastography: A Retrospective Study

Connor M. Bunch, Anthony Thomas, John E. Stillson, Laura Gillespie, Rashid Z. Khan, Nuha Zackariya, Faadil Shariff, Mahmoud Al-Fadhl, Nicolas Mjaess, Peter D. Miller, Michael T. McCurdy, Daniel H. Fulkerson, Joseph B. Miller, Hau C. Kwaan, Ernest E. Moore, Hunter B. Moore, Matthew D. Neal, Peter L. Martin, Mark L. Kricheff, Mark M. Walsh

Summary: This study highlights the importance of implementing a precision-based titration strategy for anticoagulation in hospitalized COVID-19 patients to prevent thrombotic and bleeding complications.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Article Pathology

Characterisation of antithrombin-dependent anticoagulants through clot waveform analysis to potentially distinguish them from antithrombin-independent inhibitors targeting activated coagulation factors

Masatoshi Wakui, Yuta Fujimori, Shoko Nakamura, Shusaku Oka, Yuko Ozaki, Yoshino Kondo, Terumichi Nakagawa, Hisako Katagiri, Mitsuru Murata

Summary: This study successfully differentiated antithrombin-dependent and antithrombin-independent inhibitors through clot waveform analysis, providing insights into the pharmacological aspects of anticoagulation and screening for novel anticoagulants.

JOURNAL OF CLINICAL PATHOLOGY (2021)

Add to Collection

Article Hematology

Thrombomodulin in patients with mild to moderate bleeding tendency

Dino Mehic, Alexander Tolios, Stefanie Hofer, Cihan Ay, Helmuth Haslacher, Kate Downes, Matthias Haimel, Ingrid Pabinger, Johanna Gebhart

Summary: The study investigated sTM levels and genetic variants in the THBD gene in MBD patients to determine their association with bleeding disorders, but no significant correlation was found. It was concluded that TM-associated coagulopathy is rare in MBD patients and sTM does not impact bleeding severity or haemostasis.

HAEMOPHILIA (2021)

Add to Collection

Article Medicine, General & Internal

Inhibition of caspase-1-mediated inflammasome activation reduced blood coagulation in cerebrospinal fluid after subarachnoid haemorrhage

Yuanjian Fang, Xiaoyu Wang, Jianan Lu, Hui Shi, Lei Huang, Anwen Shao, Anke Zhang, Yibo Liu, Reng Ren, Cameron Lenahan, Jiping Tang, Jianmin Zhang, John H. Zhang, Sheng Chen

Summary: This study investigates the role of caspase-1-mediated inflammasome activation on extrinsic blood coagulation in cerebrospinal fluid (CSF) after subarachnoid hemorrhage (SAH). The results demonstrate that inhibiting caspase-1 with VX-765 can attenuate neuroinflammation and blood coagulation, leading to improved neurological outcomes and memory capacity in SAH rats. These findings suggest that VX-765 may be a potential treatment for SAH-related neuroinflammatory and hemostatic disorders.

EBIOMEDICINE (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Antiplatelet Agents and Oral Anticoagulant Use in Patients with Atrial Fibrillation and Carotid Artery Disease After First-Time Ischaemic Stroke

Stephanie L. Harrison, Benjamin J. R. Buckley, Deirdre A. Lane, Elnara Fazio-Eynullayeva, Paula Underhill, Andrew Hill, David J. Werring, Gregory Y. H. Lip

Summary: This study aimed to determine the impact of oral anticoagulants (OACs) plus antiplatelet agents (APA) on outcomes for patients with atrial fibrillation (AF) and carotid artery disease after ischemic stroke. The results suggest that receiving OACs without APA is associated with a lower risk of major bleeding and no negative impact on recurrent stroke or mortality in patients with AF and carotid artery disease. Evidence from randomized trials is needed to confirm this finding.

CARDIOVASCULAR DRUGS AND THERAPY (2023)

Add to Collection

Article Obstetrics & Gynecology

Early and systematic administration of fibrinogen concentrate in postpartum haemorrhage following vaginal delivery: the FIDEL randomised controlled trial

A. S. Ducloy-Bouthors, F. J. Mercier, J. M. Grouin, F. Bayoumeu, J. Corouge, A. Le Gouez, T. Rackelboom, F. Broisin, F. Vial, A. Luzi, O. Capronnier, C. Huissoud, A. Mignon

Summary: This study aimed to assess the benefits and safety of early human fibrinogen concentrate in postpartum haemorrhage management, with results showing that 3 g fibrinogen concentrate did not significantly reduce blood loss or transfusion needs in PPH management, but did prevent plasma fibrinogen decrease and was considered safe.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Monitoring of Anticoagulant Activity of Dabigatran and Rivaroxaban in the Presence of Heparins

Aleksandra Jakimczuk, Bartlomiej Kalaska, Kamil Kaminski, Joanna Miklosz, Shin-Ichi Yusa, Dariusz Pawlak, Krzysztof Szczubialka, Andrzej Mogielnicki

Summary: This study developed a method to monitor the anticoagulant activity of DOACs in the presence of heparins using HBC and polybrene. These agents neutralized heparins and enabled accurate monitoring of DOACs' activity.

JOURNAL OF CLINICAL MEDICINE (2022)

Add to Collection

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.